Dr. John Evans:

I have not spotted that yet. The regime is at an earlier stage. I would say the regulatory challenges are with the bigger entities for the moment. We will then move down through that kind of scenario later. For me, that is sort of a mature regulatory situation. It kind of goes to that risk point. If it is a very big entity with a lot of members and users, simply switching names is not going to be an effective mechanism for evading regulation.